{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T11:52:08Z","timestamp":1765453928679,"version":"3.46.0"},"reference-count":45,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>(1) Background: Mongolia has historically reported one of the highest hepatitis C virus (HCV) prevalence rates globally, with past national estimates exceeding 15%, making HCV infection a major public health priority. This study aimed to assess the prevalence, genotype distribution, and risk factors of HCV infection among residents of Arkhangai Province. (2) Methods: This population-based cross-sectional study was conducted in 2022 including 2304 individuals aged 0\u201380 years. Serum samples were tested for anti-HCV antibodies using ELISA and for HCV RNA using PCR. Positive samples were genotyped, and demographic and exposure data were analyzed using logistic regression to identify independent risk factors. (3) Results: The prevalence of anti-HCV antibodies was 12.0%, and HCV RNA positivity was 7.16%. Infection increased significantly with age (p &lt; 0.001) and was higher among females (14.6%) than males (8.4%). Genotype 1b predominated (98.2%), followed by 1a (1.2%) and 2 (0.6%). Several exposures showed strong associations with HCV infection in univariate analysis, including cupping therapy (OR 2.37, 95% CI 1.71\u20133.28), shared razor use (OR 2.39, 95% CI 1.59\u20133.60), cosmetic procedures (OR 1.70, 95% CI 1.11\u20132.45), and unsafe injections (OR 2.06, 95% CI 1.40\u20133.02). In multivariable analysis, four exposures remained independently associated with HCV infection: cupping therapy (adjusted OR 1.89, 95% CI 1.32\u20132.70), shared razor use (adjusted OR 1.98, 95% CI 1.24\u20132.89), cosmetic procedures (adjusted OR 1.62, 95% CI 1.39\u20132.24), and unsafe injections (adjusted OR 1.84, 95% CI 1.19\u20132.83). (4) Conclusions: HCV infection remains prevalent, particularly among older adults and women. Genotype 1b continues to predominate, indicating that the viral genetic distribution has remained largely unchanged over the past decade. Continued education, safe injection practices, and regulation of traditional and cosmetic procedures are essential to reduce HCV transmission and support Mongolia\u2019s elimination goals. These findings highlight the need for comprehensive prevention strategies addressing both unsafe traditional\/medical practices and the rapidly expanding cosmetic and aesthetic service sector.<\/jats:p>","DOI":"10.3390\/v17121602","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T11:17:27Z","timestamp":1765451847000},"page":"1602","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatitis C Virus Infection in Mongolia: Updated Provincial Data on Prevalence, Genotype Distribution, and Age-Specific Risk Factors"],"prefix":"10.3390","volume":"17","author":[{"given":"Amgalan","family":"Byambasuren","sequence":"first","affiliation":[{"name":"Department of Health Research, Graduate School, Mongolian National University of Medical Sciences, Ulaanbaatar 14210, Mongolia"},{"name":"General Hospital, Tsetserleg 6519, Mongolia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myagmarjaltsan","family":"Baatarzorigt","sequence":"additional","affiliation":[{"name":"General Hospital, Tsetserleg 6519, Mongolia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munkhtuya","family":"Otgon","sequence":"additional","affiliation":[{"name":"Soum Health Center of the Arkhangai Province, Ulaanbaatar 15141, Mongolia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byambasuren","family":"Bat-Amgalan","sequence":"additional","affiliation":[{"name":"Department of Administration, Mongolian National University of Medical Sciences, Ulaanbaatar 14210, Mongolia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandakhnaran","family":"Purevkhuu","sequence":"additional","affiliation":[{"name":"Department of Administration, Mongolian National University of Medical Sciences, Ulaanbaatar 14210, Mongolia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naranzul","family":"Nyamsuren","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar 14210, Mongolia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enkh-Amar","family":"Ayush","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar 14210, Mongolia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dashchirev","family":"Munkh-Orshikh","sequence":"additional","affiliation":[{"name":"National Cancer Center, Ulaanbaatar 13370, Mongolia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khurelbaatar","family":"Nyamdavaa","sequence":"additional","affiliation":[{"name":"Department of Administration, Mongolian National University of Medical Sciences, Ulaanbaatar 14210, Mongolia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0769-3693","authenticated-orcid":false,"given":"Oidov","family":"Baatarkhuu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar 14210, Mongolia"},{"name":"Mongolian Academy of Sciences, Ulaanbaatar 13330, Mongolia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2024). Implementing the Global Health Sector Strategies on HIV, Viral Hepatitis and Sexually Transmitted Infections, 2022\u20132030: Report on Progress and Gaps 2024, World Health Organization."},{"key":"ref_2","unstructured":"WHO Annex (2021). Global Progress Report on HIV, Viral Hepatitis and Sexually Transmitted Infections, WHO Annex. Available online: https:\/\/iris.who.int\/."},{"key":"ref_3","unstructured":"World Health Organization (2024). Global Hepatitis Report 2024: Action for Access in Low- and Middle-Income Countries, World Health Organization."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"180257","DOI":"10.1098\/rsos.180257","article-title":"The epidemiology of hepatitis C virus in Pakistan: Systematic review and meta-analyses","volume":"5","author":"Mahmud","year":"2018","journal-title":"R. Soc. Open Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.30297","article-title":"Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013\u20132016","volume":"69","author":"Hofmeister","year":"2018","journal-title":"Hepatology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5005\/jp-journals-10018-1260","article-title":"Epidemiology, Genotype Distribution, Prognosis, Control, and Management of Viral Hepatitis B, C, D, and Hepatocellular Carcinoma in Mongolia","volume":"8","author":"Baatarkhuu","year":"2018","journal-title":"Euroasian J. Hepato-Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s12072-011-9325-4","article-title":"Clinical features and prognosis of hepatocellular carcinoma in Mongolia: A multicentre study","volume":"6","author":"Baatarkhuu","year":"2012","journal-title":"Hepatol. Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/jmv.20482","article-title":"High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia","volume":"77","author":"Takahashi","year":"2005","journal-title":"J. Med. Virol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/j.1478-3231.2008.01820.x","article-title":"Prevalence and genotype distribution of hepatitis C virus among apparently healthy individuals in Mongolia: A population-based nationwide study","volume":"28","author":"Baatarkhuu","year":"2008","journal-title":"Liver Int."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Dorj, G., Baatarkhuu, O., Dorj, G., Lkhagvaa, U., Walsh, N., Choijoo, A., Gurbadam, U., Jargalsaikhan, J., and Erdenetsetseg, B. (2025). Viral hepatitis elimination in Mongolia. Viral Hepatitis in Asia and the Pacific, Academic Press.","DOI":"10.1016\/B978-0-443-23629-7.00007-3"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3350\/cmh.2020.0023","article-title":"Efficacy and safety of ledipasvir\/sofosbuvir in 5028 Mongolian patients infected with genotype 1 hepatitis C virus: A multicenter study","volume":"27","author":"Baatarkhuu","year":"2020","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Dambadarjaa, D., Radnaa, O., Khuyag, S.-O., Shagdarsuren, O.-E., Enkhbayar, U., Mukhtar, Y., Tsogzolbaatar, E.-O., Nyam, G., Shaarii, S., and Singh, P. (2022). Hepatitis B, C, and D Virus Infection among Population Aged 10\u201364 Years in Mongolia: Baseline Survey Data of a Nationwide Cancer Cohort Study. Vaccines, 10.","DOI":"10.3390\/vaccines10111928"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Mohlman, M.K., Saleh, D.A., Ezzat, S., Abdel-Hamid, M., Korba, B., Shetty, K., Amr, S., and Loffredo, C.A. (2015). Viral transmission risk factors in an Egyptian population with high hepatitis C prevalence. BMC Public Health, 15.","DOI":"10.1186\/s12889-015-2369-y"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Xu, H., Yu, G., Sun, H., Lv, J., Wang, M., Kong, F., Zhang, M., Chi, X., Wang, X., and Wu, R. (2015). Use of parenteral caffeinum natrio-benzoicum: An underestimated risk factor for HCV transmission in China. BMC Public Health, 15.","DOI":"10.1186\/s12889-015-2299-8"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4103\/ijpvm.IJPVM_94_20","article-title":"Unsafe practices associated with HCV infection among adults: A case control study","volume":"12","author":"Heiza","year":"2021","journal-title":"Int. J. Prev. Med."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Stroffolini, T., and Stroffolini, G. (2024). Prevalence and modes of transmission of hepatitis C virus infection: A historical worldwide review. Viruses, 16.","DOI":"10.3390\/v16071115"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/BF01718286","article-title":"Prevalence of hepatitis C virus and distribution of its genotypes in Northern Eurasia","volume":"141","author":"Lovo","year":"1996","journal-title":"Arch. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.3748\/wjg.v22.i34.7824","article-title":"Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes","volume":"22","author":"Petruzziello","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_19","first-page":"435","article-title":"Using Phylogenetic Analysis to Detect National and International Dimensions of Hepatitis C Virus 1b Transmission Clusters\u2014China, 1989\u20132021","volume":"7","author":"Jiang","year":"2025","journal-title":"China CDC Wkly."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"9289","DOI":"10.1038\/s41598-025-91696-4","article-title":"Micro-elimination initiative for hepatitis C screening: Insight into gender gaps and undiagnosed individuals","volume":"15","author":"Piazzolla","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1038\/s41598-023-29262-z","article-title":"Gender differences in prevalence of hepatitis C virus infection in Egypt: A systematic review and meta-analysis","volume":"13","author":"Nour","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/ijc.28753","article-title":"REVEAL-HCV Study Group. Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma","volume":"135","author":"Lee","year":"2014","journal-title":"Int. J. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"17006","DOI":"10.1038\/nrdp.2017.6","article-title":"Hepatitis C virus infection","volume":"3","author":"Manns","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Byambasuren, A., Gyarvuulkhasuren, B., Erdenebat, B., Nyamdavaa, K., and Baatarkhuu, O. (2025). Long-Term Outcomes of Ledipasvir\/Sofosbuvir Treatment in Hepatitis C: Viral Suppression, Hepatocellular Carcinoma, and Mortality in Mongolia. Viruses, 17.","DOI":"10.3390\/v17060743"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"6380","DOI":"10.3748\/wjg.v28.i45.6380","article-title":"Best therapy for the easiest to treat hepatitis C virus genotype 1b-infected patients","volume":"28","author":"Jaroszewicz","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.annepidem.2018.03.007","article-title":"Individual-level key associations and modes of exposure for hepatitis C virus infection in the Middle East and North Africa: A systematic synthesis","volume":"28","author":"Mahmud","year":"2018","journal-title":"Ann. Epidemiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1721727X221144391","article-title":"Hepatitis C virus: Its prevalence, risk factors and genotype distribution in Pakistan","volume":"20","author":"Saleem","year":"2022","journal-title":"Eur. J. Inflamm."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4274\/vhd.galenos.2021.2021-1-3","article-title":"Demographic characteristics and transmission risk factors of patients with hepatitis C virus in Turkey: The EPI-C, a multicenter and cross-sectional trial","volume":"27","author":"Tabak","year":"2021","journal-title":"Viral Hepat. J."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Gizamba, J.M., Finch, B.K., Wang, S., and Klausner, J.D. (2025). Insights into the spatial epidemiology of hepatitis C infection: Systematic synthesis of area-level determinants and spatiotemporal analyses. BMC Public Health, 25.","DOI":"10.1186\/s12889-025-21668-w"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/jvh.12295","article-title":"Hepatitis C virus infection in China: An emerging public health issue","volume":"22","author":"Qin","year":"2015","journal-title":"J. Viral Hepat."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4166\/kjg.2023.060","article-title":"Risk of Hepatitis C Virus Transmission through Acupuncture: A Systematic Review and Meta-Analysis","volume":"82","author":"Hyun","year":"2023","journal-title":"Korean J. Gastroenterol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Suan, M.A.M., Said, S.M., Lim, P.Y., Azman, A.Z.F., and Abu Hassan, M.R. (2019). Risk factors for hepatitis C infection among adult patients in Kedah state, Malaysia: A case\u2013control study. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0224459"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.29245\/2689-9981\/2018\/2.1113","article-title":"Unsafe Injection Practices by Medical Practitioners in South Asia Associated with Hepatitis and HIV Outbreaks","volume":"1","author":"Altaf","year":"2018","journal-title":"J. Infect."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"P\u00e9pin, J., Chakra, C.N.A., P\u00e9pin, E., Nault, V., and Valiquette, L. (2014). Evolution of the Global Burden of Viral Infections from Unsafe Medical Injections, 2000\u20132010. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0099677"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ijid.2021.02.040","article-title":"Prevalence and genotype distribution of hepatitis C virus in Mongolia: Systematic review and meta-analysis","volume":"105","author":"Chaabna","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S2468-1253(19)30085-8","article-title":"The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: A modelling study","volume":"4","author":"Trickey","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.4103\/jfmpc.jfmpc_1965_21","article-title":"Epidemiological correlates of hepatitis C infection- A case control analysis from a tertiary care hospital","volume":"11","author":"Sharma","year":"2022","journal-title":"J. Fam. Med. Prim. Care"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/cid\/cir991","article-title":"Transmission of hepatitis C virus infection through tattooing and piercing: A critical review","volume":"54","author":"Tohme","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5009\/gnl14403","article-title":"Risk Factors for Hepatitis C Virus (HCV) Infection in Areas with a High Prevalence of HCV in the Republic of Korea in 2013","volume":"10","author":"Sohn","year":"2016","journal-title":"Gut Liver"},{"key":"ref_40","first-page":"519","article-title":"Risk factors associated with HCV infection among adults in Damietta Governorate, Egypt","volume":"11","author":"Salama","year":"2020","journal-title":"J. Clin. Anal. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3350\/cmh.2016.0055","article-title":"Acute hepatitis A, B and C but not D is still prevalent in Mongolia: A time trend analysis","volume":"23","author":"Baatarkhuu","year":"2017","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"s375","DOI":"10.1017\/ice.2020.1006","article-title":"Risk Factors Associated with Acute Hepatitis C in Mongolia","volume":"41","author":"Chunt","year":"2020","journal-title":"Infect. Control. Hosp. Epidemiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5005\/jp-journals-10018-1215","article-title":"Viral Hepatitis and Liver Diseases in Mongolia","volume":"7","author":"Baatarkhuu","year":"2017","journal-title":"Euroasian J. Hepato-Gastroenterol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e2438657","DOI":"10.1001\/jamanetworkopen.2024.38657","article-title":"Prevalence of HCV Infection Among People Experiencing Homelessness in Madrid, Spain","volume":"7","author":"Ryan","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2300712","DOI":"10.2807\/1560-7917.ES.2024.29.29.2300712","article-title":"Decrease in active hepatitis C infection among people who use drugs in Madrid, Spain, 2017 to 2023: A retrospective study","volume":"29","author":"Ryan","year":"2024","journal-title":"Eurosurveillance"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/12\/1602\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T11:22:04Z","timestamp":1765452124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/12\/1602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":45,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["v17121602"],"URL":"https:\/\/doi.org\/10.3390\/v17121602","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]}}}